Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

1,918 public trials 364 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

NCT04570839

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Oncology Center. Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
View Trial Details
Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

NCT02383927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Endocrine Gland Neoplasms, +13 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Wihship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 35 locations
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Completed

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

NCT03719690

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • The Oncology Institute of Hope and Innovation - Anaheim Whittier, California, United States
View all 102 locations
View Trial Details

Related conditions